Molecular Characterization by Whole-Genome Sequencing of Clinical and Environmental Serratia marcescens Strains Isolated during an Outbreak in a Neonatal Intensive Care Unit (NICU)
Abstract
:1. Introduction
2. Materials and Methods
2.1. Clinical Strains
2.2. Environmental Sampling
2.3. Testing for Antimicrobial Susceptibility
2.4. Whole-Genome Sequencing (WGS)
2.5. SRT-3 Extraction and β-Lactamase Activity
3. Results
3.1. Epidemiological Outbreak
3.2. Antimicrobial Susceptibility
3.3. WGS Analysis
3.4. Characterization of SRT-3 β-Lactamase
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Keck, N.; Dunie-Merigot, A.; Dazas, M.; Hirchaud, E.; Laurence, S.; Gervais, B.; Madec, J.Y.; Haenni, M. Long-lasting nosocomial persistence of chlorhexidine-resistant Serratia marcescens in a veterinary hospital. Vet. Microbiol. 2020, 245, 108686. [Google Scholar] [CrossRef] [PubMed]
- Fernández, L.; Hancock, R.E. Adaptive and mutational resistance: Role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 2012, 25, 661–681. [Google Scholar] [CrossRef]
- Sunenshine, R.H.; Tan, E.T.; Terashita, D.M.; Jensen, B.J.; Kacica, M.A.; Sickbert-Bennett, E.E.; Noble-Wang, J.A.; Palmieri, M.J.; Bopp, D.J.; Jernigan, D.B.; et al. A multistate outbreak of Serratia marcescens bloodstream infection associated with contaminated intravenous magnesium sulfate from a compounding pharmacy. Clin. Infect. Dis. 2007, 45, 527–533. [Google Scholar] [CrossRef]
- Åttman, E.; Korhonen, P.; Tammela, O.; Vuento, R.; Aittoniemi, J.; Syrjänen, J.; Mattila, E.; Österblad, M.; Huttunen, R. A Serratia marcescens outbreak in a neonatal intensive care unit was successfully managed by rapid hospital hygiene interventions and screening. Acta Paediatr. 2018, 107, 425–429. [Google Scholar] [CrossRef]
- Voelz, A.; Müller, A.; Gillen, J.; Le, C.; Dresbach, T.; Engelhart, S.; Exner, M.; Bates, C.J.; Simon, A. Outbreaks of Serratia marcescens in neonatal and pediatric intensive care units: Clinical aspects, risk factors and management. Int. J. Hyg. Environ. Health 2010, 213, 79–87. [Google Scholar] [CrossRef] [PubMed]
- Greco-Stewart, V.S.; Brown, E.E.; Parr, C.; Kalab, M.; Jacobs, M.R.; Yomtovian, R.A.; Ramírez-Arcos, S.M. Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture. Vox Sang. 2012, 102, 212–220. [Google Scholar] [CrossRef] [PubMed]
- Martineau, C.; Li, X.; Lalancette, C.; Perreault, T.; Fournier, E.; Tremblay, J.; Gonzales, M.; Yergeau, É.; Quach, C. Serratia marcescens outbreak in a neonatal intensive care unit: New insights from next-generation sequencing applications. J. Clin. Microbiol. 2018, 56, e00235-18. [Google Scholar] [CrossRef]
- Moles, L.; Gomez, M.; Moroder, E.; Jimenez, E.; Escuder, D.; Bustos, G.; Melgar, A.; Vila, J.; Del Campo, R.; Chaves, F.; et al. Serratia marcescens colonization in preterm neonates during their neonatal intensive care unit stay. Antimicrob. Resist. Infect. Control 2019, 8, 135. [Google Scholar] [CrossRef]
- da Silva, K.E.; Rossato, L.; Jorge, S.; de Oliveira, N.R.; Kremer, F.S.; Campos, V.F.; da Silva Pinto, L.; Dellagostin, O.A.; Simionatto, S. Three challenging cases of infections by multidrug-resistant Serratia marcescens in patients admitted to intensive care units. Braz. J. Microbiol. 2021, 52, 1341–1345. [Google Scholar] [CrossRef]
- Yeo, K.T.; Octavia, S.; Lim, K.; Lin, C.; Lin, R.; Thoon, K.C.; Tee, N.W.S.; Yung, C.F. Serratia marcescens in the neonatal intensive care unit: A cluster investigation using molecular methods. J. Infect. Public Health 2020, 13, 1006–1011. [Google Scholar] [CrossRef]
- Muyldermans, A.; Crombé, F.; Bosmans, P.; Cools, F.; Piérard, D.; Wybo, I. Serratia marcescens outbreak in a neonatal intensive care unit and the potential of whole-genome sequencing. J. Hosp. Infect. 2021, 111, 148–154. [Google Scholar] [CrossRef] [PubMed]
- Cristina, M.L.; Sartini, M.; Spagnolo, A.M. Serratia marcescens infections in Neonatal Intensive Care Units (NICUs). Int. J. Environ. Res. Public Health 2019, 16, 610. [Google Scholar] [CrossRef]
- Al Jarousha, A.M.; El Qouqa, A.; El Jadba, A.H.; Al Afifi, A.S. An outbreak of Serratia marcescens septicaemia in neonatal intensive care unit in Gaza City, Palestine. J. Hosp. Infect. 2008, 70, 119–126. [Google Scholar] [CrossRef] [PubMed]
- Su, L.H.; Ou, J.T.; Leu, H.S.; Chiang, P.C.; Chiu, Y.P.; Chia, J.H.; Kuo, A.J.; Chiu, C.H.; Chu, C.; Wu, T.L.; et al. Extended epidemic of nosocomial urinary tract infections caused by Serratia marcescens. J. Clin. Microbiol. 2003, 41, 4726–4732. [Google Scholar] [CrossRef] [PubMed]
- Arslan, U.; Erayman, I.; Kirdar, S.; Yuksekkaya, S.; Cimen, O.; Tuncer, I.; Bozdogan, B. Serratia marcescens sepsis outbreak in a neonatal intensive care unit. Pediatr. Int. 2010, 52, 208–212. [Google Scholar] [CrossRef] [PubMed]
- European Centre for Disease Prevention and Control. Healthcare-Associated Infections in Intensive Care Units—Annual Epidemiological Report for 2017; ECDC: Stockholm, Sweden, 2019.
- Iguchi, A.; Nagaya, Y.; Pradel, E.; Ooka, T.; Ogura, Y.; Katsura, K.; Kurokawa, K.; Oshima, K.; Hattori, M.; Parkhill, J.; et al. Genome evolution and plasticity of Serratia marcescens, an important multidrug-resistant nosocomial pathogen. Genome Biol. Evol. 2014, 6, 2096–2110. [Google Scholar] [CrossRef]
- Luzzaro, F.; Perilli, M.; Migliavacca, R.; Lombardi, G.; Micheletti, P.; Agodi, A.; Stefani, S.; Amicosante, G.; Pagani, L. Repeated epidemics caused by extended-spectrum β-lactamase-producing Serratia marcescens strains. Eur. J. Clin. Microbiol. Infect. Dis. 1998, 17, 629–636. [Google Scholar] [CrossRef]
- Pérez-Viso, B.; Hernández-García, M.; Ponce-Alonso, M.; Morosini, M.I.; Ruiz-Garbajosa, P.; Del Campo, R.; Cantón, R. Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid ty** in a hospital in Madrid, Spain (2016-18). J. Antimicrob. Chemother. 2021, 76, 110–116. [Google Scholar] [CrossRef]
- Messaoudi, A.; Mansour, W.; Tilouche, L.; Châtre, P.; Drapeau, A.; Chaouch, C.; Azaiez, S.; Bouallègue, O.; Madec, J.Y.; Haenni, M. First report of carbapenemase OXA-181-producing Serratia marcescens. J. Glob. Antimicrob. Resist. 2021, 26, 205–206. [Google Scholar] [CrossRef]
- Bielli, A.; Piazza, A.; Cento, V.; Comandatore, F.; Lepera, V.; Gatti, M.; Brioschi, P.; Vismara, C.; Bandi, C.; Perno, C.F. In vivo acquisition and risk of inter-species spread of bla(KPC-3)-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract. J. Med. Microbiol. 2020, 69, 82–86. [Google Scholar] [CrossRef]
- Cai, J.C.; Zhou, H.W.; Zhang, R.; Chen, G.X. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob. Agents Chemother. 2008, 52, 2014–2018. [Google Scholar] [CrossRef] [PubMed]
- de Vries, J.J.; Baas, W.H.; van der Ploeg, K.; Heesink, A.; Degener, J.E.; Arends, J.P. Outbreak of Serratia marcescens colonization and infection traced to a healthcare worker with long-term carriage on the hands. Infect. Control Hosp. Epidemiol. 2006, 27, 1153–1158. [Google Scholar] [CrossRef] [PubMed]
- Bagattini, M.; Crispino, M.; Gentile, F.; Barretta, E.; Schiavone, D.; Boccia, M.C.; Triassi, M.; Zarrilli, R. A nosocomial outbreak of Serratia marcescens producing inducible Amp C-type β-lactamase enzyme and carrying antimicrobial resistance genes within a class 1 integron. J. Hosp. Infect. 2004, 56, 29–33. [Google Scholar] [CrossRef] [PubMed]
- Miao, M.; Wen, H.; Xu, P.; Niu, S.; Lv, J.; **. Am. J. Infect. Control. 2008, 36, 22–28. [Google Scholar] [CrossRef]
- David, M.D.; Weller, T.M.; Lambert, P.; Fraise, A.P. An outbreak of Serratia marcescens on the neonatal unit: A tale of two clones. J. Hosp. Infect. 2006, 63, 27–33. [Google Scholar] [CrossRef]
- Polilli, E.; Parruti, G.; Fazii, P.; D’Antonio, D.; Palmieri, D.; D’Incecco, C.; Mangifesta, A.; Garofalo, G.; Del Duca, L.; D’Amario, C.; et al. Rapidly controlled outbreak of Serratia marcescens infection/colonisations in a neonatal intensive care unit, Pescara General Hospital, Pescara, Italy, April 2011. Euro. Surveill. 2011, 16, 19892. [Google Scholar] [CrossRef]
- Buttinelli, E.; Ardoino, I.; Domeniconi, G.; Lanzoni, M.; Pugni, L.; Ronchi, A.; Mosca, F.; Biganzoli, E.; Castaldi, S. Epidemiology of Serratia marcescens infections in NICU of a teaching and research hospital in northern Italy. Minerva Pediatr. 2017. [Google Scholar] [CrossRef]
- Montagnani, C.; Cocchi, P.; Lega, L.; Campana, S.; Biermann, K.P.; Braggion, C.; Pecile, P.; Chiappini, E.; de Martino, M.; Galli, L. Serratia marcescens outbreak in a neonatal intensive care unit: Crucial role of implementing hand hygiene among external consultants. BMC Infect. Dis. 2015, 15, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Casolari, C.; Pecorari, M.; Della Casa, E.; Cattani, S.; Venturelli, C.; Fabio, G.; Tagliazucchi, S.; Serpini, G.F.; Migaldi, M.; Marchegiano, P.; et al. Serratia marcescens in a neonatal intensive care unit: Two long-term multiclone outbreaks in a 10-year observational study. New Microbiol. 2013, 36, 373–383. [Google Scholar] [PubMed]
- Perotti, G.; Bernardo, M.E.; Spalla, M.; Matti, C.; Stronati, M.; Pagani, L. Rapid control of two outbreaks of Serratia marcescens in a Northern Italian neonatal intensive care unit. J. Chemother. 2007, 2, 56–60. [Google Scholar] [CrossRef] [PubMed]
- Li, H.; Wang, X.; Zhang, Y.; Zhao, C.; Chen, H.; Jiang, S.; Zhang, F.; Wang, H. The role of RND efflux pump and global regulators in tigecycline resistance in clinical Acinetobacter baumannii isolates. Future Microbiol. 2015, 10, 337–346. [Google Scholar] [CrossRef]
- Yoon, E.J.; Balloy, V.; Fiette, L.; Chignard, M.; Courvalin, P.; Grillot Courvalin, C. Contribution of the Ade resistance–nodulation–cell division-type efflux pumps to fitness and pathogenesis of Acinetobacter baumannii. MBio 2016, 7, e00697-16. [Google Scholar] [CrossRef]
- Vakulskas, C.A.; Potts, A.H.; Babitzke, P.; Ahmer, B.M.; Romeo, T. Regulation of bacterial virulence by Csr (Rsm) systems. Microbiol. Mol. Biol. Rev. 2015, 79, 193–224. [Google Scholar] [CrossRef]
- Wissel, M.C.; Weiss, D.S. Genetic analysis of the cell division protein FtsI (PBP3): Amino acid substitutions that impair septal localization of FtsI and recruitment of FtsN. J. Bacteriol. 2004, 186, 490–502. [Google Scholar] [CrossRef]
- Sauvage, E.; Kerff, F.; Terrak, M.; Ayala, J.A.; Charlier, P. The penicillin-binding proteins: Structure and role in peptidoglycan biosynthesis. FEMS Microbiol. Rev. 2008, 32, 234–258. [Google Scholar] [CrossRef]
- Jakubu, V.; Malisova, L.; Musilek, M.; Pomorska, K.; Zemlickova, H. Characterization of Haemophilus influenzae strains with non-enzymatic resistance to β-lactam antibiotics caused by mutations in the PBP3 gene in the Czech Republic in 2010–2018. Life 2021, 11, 1260. [Google Scholar] [CrossRef]
- Bolourchi, N.; Noori Goodarzi, N.; Giske, C.G.; Nematzadeh, S.; Haririzadeh Jouriani, F.; Solgi, H.; Badmasti, F. Comprehensive pan-genomic, resistome and virulome analysis of clinical OXA-48 producing carbapenem-resistant Serratia marcescens strains. Gene 2022, 822, 146355. [Google Scholar] [CrossRef]
- Shaw, K.J.; Rather, P.N.; Sabatelli, F.J.; Mann, P.; Munayyer, H.; Mierzwa, R.; Petrikkos, G.L.; Hare, R.S.; Miller, G.H.; Bennett, P.; et al. Characterization of the chromosomal aac(6′)-Ic gene from Serratia marcescens. Antimicrob. Agents Chemother. 1992, 36, 1447–1455. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Agersø, Y.; Guardabassi, L. Identification of Tet 39, a novel class of tetracycline resistance determinant in Acinetobacter spp. of environmental and clinical origin. J. Antimicrob. Chemother. 2005, 55, 566–569. [Google Scholar] [CrossRef] [PubMed]
- Thompson, S.A.; Maani, E.V.; Lindell, A.H.; King, C.J.; McArthur, J.V. Novel tetracycline resistance determinant isolated from an environmental strain of Serratia marcescens. Appl. Environ. Microbiol. 2007, 73, 2199–2206. [Google Scholar] [CrossRef] [PubMed]
- Matsumura, N.; Minami, S.; Mitsuhashi, S. Sequences of homologous β-lactamases from clinical isolates of Serratia marcescens with different substrate specificities. Antimicrob. Agents Chemother. 1998, 42, 176–179. [Google Scholar] [CrossRef] [PubMed]
- Yu, W.L.; Ko, W.C.; Cheng, K.C.; Chen, H.E.; Lee, C.C.; Chuang, Y.C. Institutional spread of clonally related Serratia marcescens isolates with a novel AmpC cephalosporinase (S4): A 4-year experience in Taiwan. Diagn. Microbiol. Infect. Dis. 2008, 61, 460–467. [Google Scholar] [CrossRef]
- Mack, A.R.; Barnes, M.D.; Taracila, M.A.; Hujer, A.M.; Hujer, K.M.; Cabot, G.; Feldgarden, M.; Haft, D.H.; Klimke, W.; van den Akker, F.; et al. A standard numbering scheme for Class C β-Lactamases. Antimicrob. Agents Chemother. 2020, 64, e01841-19. [Google Scholar] [CrossRef] [Green Version]
- Perilli, M.; Celenza, G.; Pellegrini, C.; Amicosante, G. Chapter 13—β-Lactamases as major mechanism of resistance in Gram-negative bacteria. In Multidrug Resistance: A Global Concern; Khan, A.U., Zarrilli, R., Eds.; Bentham Science Publishers: Sharjah, United Arab Emirates, 2012; pp. 210–226. [Google Scholar]
Antibiotics | S. marcescens Clinical Strains (18 Isolates) S. marcescens Environmental Strain (1 Isolate) | |
---|---|---|
MIC (mg/L) | Interpretation | |
Amoxicillin/clavulanate | >16 | R |
Piperacillin/tazobactam | <4 | S |
Cefepime | <0.12 | S |
Cefotaxime | <0.12 | S |
Ceftazidime | <0.12 | S |
Ertapenem | <0.12 | S |
Meropenem | <0.12 | S |
Ciprofloxacin | <0.12 | S |
Amikacin | <1 | S |
Gentamicin | <1 | S |
Fosfomycin | 32 | S |
Colistin | >8 | R |
Strains (n. Isolates) | Genome Size (bp) | Β-Lactamase Genes | Other ARGs | Virulence Factors |
---|---|---|---|---|
S. marcescens (18) | 4.864.007–4.876.696 | blaSRT-3 | aac(6′)-Ic tetA(41) qacG | adeFGH CRP rsmA PBP3 (D350N) |
S. marcescens (1) cradles | 4.874.964 | blaSRT-3 | aac(6′)-Ic tetA(41) qacG | adeFGH CRP rsmA PBP3 (D350N) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Piccirilli, A.; Cherubini, S.; Brisdelli, F.; Fazii, P.; Stanziale, A.; Di Valerio, S.; Chiavaroli, V.; Principe, L.; Perilli, M. Molecular Characterization by Whole-Genome Sequencing of Clinical and Environmental Serratia marcescens Strains Isolated during an Outbreak in a Neonatal Intensive Care Unit (NICU). Diagnostics 2022, 12, 2180. https://doi.org/10.3390/diagnostics12092180
Piccirilli A, Cherubini S, Brisdelli F, Fazii P, Stanziale A, Di Valerio S, Chiavaroli V, Principe L, Perilli M. Molecular Characterization by Whole-Genome Sequencing of Clinical and Environmental Serratia marcescens Strains Isolated during an Outbreak in a Neonatal Intensive Care Unit (NICU). Diagnostics. 2022; 12(9):2180. https://doi.org/10.3390/diagnostics12092180
Chicago/Turabian StylePiccirilli, Alessandra, Sabrina Cherubini, Fabrizia Brisdelli, Paolo Fazii, Andrea Stanziale, Susanna Di Valerio, Valentina Chiavaroli, Luigi Principe, and Mariagrazia Perilli. 2022. "Molecular Characterization by Whole-Genome Sequencing of Clinical and Environmental Serratia marcescens Strains Isolated during an Outbreak in a Neonatal Intensive Care Unit (NICU)" Diagnostics 12, no. 9: 2180. https://doi.org/10.3390/diagnostics12092180